Published in Psychother Psychosom on May 11, 2017
Developing a Clinician Friendly Tool to Identify Useful Clinical Practice Guidelines: G-TRUST. Ann Fam Med (2017) 0.75
Industry sponsorship and research outcome. Cochrane Database Syst Rev (2012) 7.44
Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med (2009) 5.15
Reporting bias in drug trials submitted to the Food and Drug Administration: review of publication and presentation. PLoS Med (2008) 3.57
Pharmaceutical research and development: what do we get for all that money? BMJ (2012) 2.79
Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med (2013) 2.49
Financial ties and conflicts of interest between pharmaceutical and tobacco companies. JAMA (2002) 2.43
When less is more: a practical approach to searching for evidence-based answers. J Med Libr Assoc (2002) 2.26
Instruments for assessing risk of bias and other methodological criteria of published animal studies: a systematic review. Environ Health Perspect (2013) 2.21
Effect of outpatient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns. Cochrane Database Syst Rev (2010) 2.11
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev (2014) 2.10
Should we treat subclinical hypothyroidism? BMJ (2008) 2.04
What should physicians know about hypertension? The implicit knowledge requirements in the maintenance of certification self-assessment module. Fam Med (2007) 2.03
Teaching evidence-based medicine: should we be teaching information management instead? Acad Med (2005) 1.77
How to write an evidence-based clinical review article. Am Fam Physician (2002) 1.71
Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses. BMJ (2012) 1.58
Updating clinical knowledge: an evaluation of current information alerting services. Int J Med Inform (2010) 1.57
CONSORT 2010. Lancet (2010) 1.50
Entrustable professional activities in family medicine. J Grad Med Educ (2013) 1.43
Combination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure. Am Fam Physician (2003) 1.40
Medicaid drug selection committees and inadequate management of conflicts of interest. JAMA Intern Med (2013) 1.39
Author's specialty and conflicts of interest contribute to conflicting guidelines for screening mammography. J Clin Epidemiol (2012) 1.28
Priority medicines for maternal and child health: a global survey of national essential medicines lists. PLoS One (2012) 1.19
Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials (2009) 1.19
Glucose control in hospitalized patients. Am Fam Physician (2010) 1.18
Conflicts of interest and the quality of recommendations in clinical guidelines. J Eval Clin Pract (2012) 1.17
The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev (2013) 1.12
Searching for unpublished data for Cochrane reviews: cross sectional study. BMJ (2013) 1.07
Availability, prices and affordability of the World Health Organization's essential medicines for children in Guatemala. Global Health (2012) 1.05
Herbal and dietary supplement--drug interactions in patients with chronic illnesses. Am Fam Physician (2008) 1.05
Randomized trials assessing calcium supplementation in healthy children: relationship between industry sponsorship and study outcomes. Public Health Nutr (2009) 0.98
Student-teacher education programme (STEP) by step: transforming medical students into competent, confident teachers. Med Teach (2014) 0.95
Mandatory disclosure of pharmaceutical industry-funded events for health professionals. PLoS Med (2009) 0.93
Life without COX 2 inhibitors. BMJ (2006) 0.93
Teaching information mastery: the case of baby Jeff and the importance of Bayes' theorem. Fam Med (2002) 0.90
Strategies for obtaining unpublished drug trial data: a qualitative interview study. Syst Rev (2013) 0.88
Interventions for tobacco use cessation in people in treatment for or recovery from substance abuse. Cochrane Libr (2012) 0.87
Disseminating drug prescribing information: the cox-2 inhibitors withdrawals. J Am Med Inform Assoc (2006) 0.87
Factors associated with results and conclusions of trials of thiazolidinediones. PLoS One (2009) 0.86
Saw palmetto for prostate disorders. Am Fam Physician (2003) 0.86
From caveat emptor to caveat venditor: time to stop the influence of money on practice guideline development. J Eval Clin Pract (2014) 0.84
Interactions between non-physician clinicians and industry: a systematic review. PLoS Med (2013) 0.83
Tobacco industry research and protection of human subjects: a case study of R. J. Reynolds. Nicotine Tob Res (2007) 0.83
Barriers and facilitators to the implementation of clinical practice guidelines: a cross-sectional survey among physicians in Estonia. BMC Health Serv Res (2012) 0.81
Review of the quality of pediatric medications in developing countries. J Pharm Sci (2013) 0.81
Could chiropractors screen for adverse drug events in the community? Survey of US chiropractors. Chiropr Osteopat (2010) 0.79
A clearer view of evidence in treating macular degeneration: off-label policies and independent research. Cochrane Database Syst Rev (2014) 0.78
Regulatory agencies hold the key to improving Cochrane reviews of drugs. Cochrane Database Syst Rev (2015) 0.77
The American Psychiatric Association's guideline for major depressive disorder: a commentary. Psychother Psychosom (2012) 0.76
Research was evidence based. BMJ (2003) 0.75
Glycemic control is an important consideration in diabetes care. In reply. Am Fam Physician (2014) 0.75
Prescribing for older adults: finding the balance. Am Fam Physician (2007) 0.75
Sleeping at home: a new model for a hospital teaching service. J Grad Med Educ (2011) 0.75
Decision-making capacity, memory and informed consent, and judgment at the boundaries of the self. J Clin Ethics (2007) 0.75
Clarification of study and citation. Arch Intern Med (2007) 0.75
Systematic reviews: perhaps "the answer to policy makers' prayers"? Environ Health Perspect (2014) 0.75
Instruments for assessing risk of bias and other methodological criteria: Krauth et al. Respond. Environ Health Perspect (2014) 0.75
Assessing and Documenting the Cognitive Performance of Family Medicine Residents Practicing Outpatient Medicine. J Grad Med Educ (2014) 0.75
Worsening of Neurologic Symptoms After Spinal Anesthesia in Two Patients With Spinal Stenosis. Reg Anesth Pain Med (2015) 0.75
"Just say no": experts' late withdrawal from cases to preserve independence and objectivity. J Am Acad Psychiatry Law (2004) 0.75
In patients with diabetes and hypertension, should treatment start with an ACE inhibitor instead of a diuretic or beta blocker? J Fam Pract (2002) 0.75
Pharmaceutical industry funding of educational events for pharmacists in Australia: an analysis of data from the first 6 months of a mandatory disclosure programme. Int J Pharm Pract (2010) 0.75
Policies affecting the supply and access of opioid analgesics: a scoping review protocol. JBI Evid Synth (2020) 0.75
Avoiding ipse dixit mislabeling: post-Daubert approaches to expert clinical opinions. J Am Acad Psychiatry Law (2003) 0.75
The Cochrane Library Oversight Committee. Cochrane Database Syst Rev (2011) 0.75
Interventions for tobacco use cessation in people in treatment for or recovery from substance use disorders. Cochrane Database Syst Rev (2016) 0.75
Prevention of osteoporosis. J Fam Pract (2002) 0.75
Blowing the whistle on review articles. BMJ (2004) 0.75